John Frederick Ek - Apr 1, 2024 Form 4 Insider Report for Akoya Biosciences, Inc. (AKYA)

Role
CFO
Signature
/s/ John Frederick Ek, by Brian McKelligon, as Attorney-in-Fact
Stock symbol
AKYA
Transactions as of
Apr 1, 2024
Transactions value $
-$65,080
Form type
4
Date filed
4/2/2024, 04:41 PM
Previous filing
Mar 1, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKYA Common Stock Tax liability -$65.1K -14.3K -7.32% $4.56 181K Apr 1, 2024 Direct F1
holding AKYA Common Stock 20K Apr 1, 2024 Ek Trust Dated November 20, 2020
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld to cover taxes on a restricted stock unit award previously granted on March 20, 2023, which vests in four (4) annual equal installments beginning on April 1, 2024 and annually thereafter until fully vested.